Dr. Daniel C. Smith has been appointed chief scientific officer at Cobra Biologics, with responsibility for developing scientific excellence across the group and enhancing Cobra’s DNA, virus, microbial and mammalian proteins R&D platforms.   Dr. Smith joins the company from HealthTech & Medicines Knowledge Transfer Network (KTN), where he served as a Knowledge Transfer Manager on the bioProcessUK team, responsible for driving the innovation agenda for biologics bioprocessing in the UK. P...